The yeast Saccharomyces cerevisiae provides an
. We wanted to determine if RPR, HID, and GRIM played a similar role exhibit apoptosis, and database searches have failed to uncover yeast homologs of the core apoptosis regulain regulating their activity. We focused our attention on drICE. A version of drICE lacking the prodomain is not tors identified in worms, flies, and mammals, overexpression of DCP-1 or drICE results in yeast cell death inhibited by DIAP1 (Hawkins et al., 1999), but a version of drICE that contains prodomain sequences is (C. J. H. that is blocked by DIAP1. Here we used yeast expressing these proteins as a system to assay the ability of RPR, and B. A. H., unpublished observations). Full-length drICE expressed in yeast under GAL1 control neither HID, and GRIM to disrupt IAP-caspase interactions. We found that all three proteins, while nontoxic on their own, kills nor activates a cleavage-dependent reporter, probably because the caspase does not significantly autoackilled yeast coexpressing DCP-1 or drICE and DIAP1, suggesting that they were blocking DIAP1's ability to tivate (Hawkins et al., 1999). We created a form of drICE that is active in yeast and contains prodomain sequences function as a caspase inhibitor. We pursued the basis for this activity further with HID and found, both in yeast by generating a "reversed" form of drICE, rev-drICE, in which the drICE p10 domain was placed N-terminal to and in vitro, that proteins containing the N-terminal 37 residues of HID, which are sufficient to induce apoptosis prodomain and p20 sequences ( Figure 1B ). Reversed forms of mammalian caspases that are not otherwise in insect cells , suppressed DIAP1's ability to inhibit DCP-1 activity. We also found that the active are constitutively active . As shown in Figure 1B , expression of rev-drICE under DIAP1 loss-of-function phenotype consists of an embryo-wide set of cellular changes reminiscent of apo-GAL1 control kills yeast, and this death is prevented by coexpression of DIAP1. Importantly, as with DCP-1, ptotic cell death and that these were associated with the activation of DIAP1-inhibitable caspase activity. Furexpression of HID, GRIM, or RPR killed yeast coexpressing rev-drICE and DIAP1. thermore, double mutants that remove zygotic rpr, hid, grim, and DIAP1 function showed phenotypes similar to those of the DIAP1 loss-of-function mutant alone.
The N Terminus of HID Mediates Its Ability These observations suggest that a principal function of
to Disrupt IAP-Caspase Interactions DIAP1 is to promote cell survival by blocking caspase in Yeast activity and that at least one mechanism by which RPR, In insect cells, the N-terminal 37 amino acids of HID, HID, and GRIM promote apoptosis is by disrupting IAPexpressed in the context of a larger fusion protein, are caspase interactions.
necessary and sufficient to induce apoptosis and to mediate HID's binding to DIAP1 . To test the activity of these sequences in yeast, we generResults and Discussion ated GAL1 expression constructs similar to those of Vucic et al. (1998) in which the first 37 amino acids of HID RPR, HID, and GRIM Block DIAP1's Ability were either present or absent ( Figure 1C ). HID⌬(38-335) to Suppress Caspase-Dependent Cell encodes a protein in which the first 37 amino acids of Death in Yeast HID are fused to the C-terminal 74; HID⌬(1-335) consists Yeast were transformed with two plasmids: one in which of only the last 74 residues of HID; and HID⌬(1-36) en-DCP-1 expression was driven by the inducible GAL1 codes a protein that lacks the first 36 residues of HID but promoter, and a second in which DIAP1 expression was contains the rest of the full-length HID coding sequence. driven by the constitutive Adh promoter (hereafter re-GAL1-dependent expression of HID⌬(38-335) in DCPferred to as DCP-1-DIAP1 yeast). These cells were then 1-DIAP1 yeast resulted in no growth. In contrast, DCPtransformed with a second GAL1 expression plasmid 1-DIAP1 yeast expressing HID⌬(1-335) grew normally. that was either an empty vector or carried GAL1-driven HID⌬(1-36) had weak killing activity in this assay ( Figure  RPR, HID or HID⌬(1-36) in isolation had no effect on yeast cell DCP-1-DIAP1 yeast carrying an empty vector survived growth ( Figure 1D ). Thus, proteins carrying the N-termion galactose, but DCP-1-DIAP1 yeast expressing HID nal 37 residues of HID, which are sufficient to kill insect or GRIM did not ( Figure 1A) . Expression of RPR under cells, are also able to kill DCP-1-DIAP1 yeast. GAL1 control did not kill DCP-1-DIAP1 yeast in which DIAP1 expression was driven by the Adh promoter, but it was able to kill DCP-1-DIAP1 yeast in which DIAP1
HID Suppresses DIAP1's Ability to Inhibit DCP-1 Caspase Activity In Vitro expression was driven by a weaker promoter, the copper-inducible CUP1 promoter, in the presence of 30 M The results of our yeast experiments suggested that HID directly inhibits DIAP1. We tested this idea in vitro using Cu 2ϩ ( Figure 1A) . Importantly, expression in yeast of RPR, HID, or GRIM alone under GAL1 control had no purified proteins. Bacterially expressed and purified versions of DCP-1, DIAP1, and HID ( Figure 2A) were mixed effect on cell growth as compared with yeast expressing only the empty vector ( Figure 1A) . These results suggest in various combinations and DCP-1 caspase activity measured fluorometrically ( Figures 2B and 2C ). His6-that RPR, HID, and GRIM are able to block DIAP1's ability to inhibit DCP-1 caspase activity.
tagged DCP-1 (DCP-1-His6) is active as a caspase, and this activity was inhibited by DIAP1 but not GST Three other Drosophila caspases, drICE, DCP-2/ Figure 2C , addition of HID(1-to a reaction containing DCP-1-His6 did not alter DCP-1-His6 activity, indicating that HID has no direct effect 37)GST-His6 to an assay containing DCP-1-His6 and DIAP1 blocked DIAP1's ability to inhibit DCP-1-His6 acon DCP-1-His6 ( Figure 2B ). However, when full-length HID was incubated with DIAP1 and DCP-1-His6, DIAP1-tivity, while addition of an equivalent amount of GSTHis6 had no effect. Thus, consistent with our observadependent inhibition of DCP-1-His6 activity was lost ( Figure 2B ). Incubation of DIAP1 and DCP-1-His6 with tions in yeast, purified HID directly blocks DIAP1's ability to inhibit DCP-1 caspase activity, and the first 37 amino HID⌬(1-36)-His6 had little or no effect on DIAP1's ability to inhibit DCP-1-His6 activity, indicating that the first acids of HID, at least in the context of a larger fusion protein, are necessary and sufficient for this activity. 37 residues of HID are necessary for this activity. To determine if the first 37 residues of HID were sufficient To determine if HID directly interacts with DIAP1 or DCP-1, we carried out binding experiments. As exto mediate this effect, we carried out experiments using a version of HID that consists of the first 37 residues of pected from the results of our yeast and in vitro activity Figures 5B and 5D ), but the intensity increases ways may be necessary to create a complete apoptotic within the following hour of development to a strong uniform labeling (Figures 5B, 5D, and 5F ). In contrast, response. expression of other IAPs, such as DIAP2, suppresses inhibits caspase activation or activity induced by these proteins (Figure 7) . some of the caspase-dependent events necessary for a full apoptotic cell death phenotype. A third possibility (discussed further below) is that loss of DIAP1 function,
Concluding Remarks while sufficient to kill cells, is not sufficient to confer all
IAPs are the only cellular caspase inhibitors identified aspects of apoptosis. In this scenario, proteins such as to date. We showed that RPR, GRIM, HID, and HID RPR, HID, or GRIM that are sufficient to trigger a full fragments sufficient to cause the death of insect cells apoptotic response when overexpressed may play dual block DIAP1's ability to inhibit caspase activity. These roles: inhibiting IAP function and, in addition, activating observations provide a mechanism for RPR, HID, and other apoptotic pathways (Figure 7) . GRIM action and define a novel point at which caspase activity can be regulated. The finding that the DIAP1 DIAP1 Is Epistatic to rpr, hid, and grim loss-of-function phenotype involves cell death associTo explore further the relationship between rpr, hid, ated with increased caspase activity strongly suggests grim, and DIAP1, we made a double mutant with the that the interactions we described between RPR, HID, H99 deficiency (which includes rpr, hid, and grim) and GRIM, DIAP1, and caspases are physiologically importh
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. Homozygous H99 embryos essentially lack apotant. Since most mammalian cells constitutively express ptosis (White et al., 1994) . However, double mutants caspases sufficient to carry out cell death (Weil et al., show a terminal embryonic phenotype similar to that of 1996), the mechanism of cell death activation defined th 5 alone (data not shown). This, in conjunction with the by these proteins may be quite general. A prediction of fact that DIAP1 is a caspase inhibitor, argues against our model of RPR, HID, and GRIM function is that their models in which DIAP1's sole antiapoptotic role is to ability to kill will depend on the status of a cell's casbind to RPR, HID, and GRIM, thereby suppressing death pases. In cells in which caspases are activated or sponpathways they activate, since in this scenario, the doutaneously undergoing autoactivation at some level, their ble mutant phenotype would be expected to be similar expression may be sufficient to kill. However, in other to that of the H99 mutant alone. Instead, our observacells in which caspase activity is either absent or more tions are consistent with models in which DIAP1 has an tightly regulated, they may function primarily to create a important antiapoptotic function as a caspase inhibitor permissive condition for caspase-dependent cell death. can1-100, leu2-3 and -112, his3-11 and -15, trp1-1, ura3-1 cessed for scanning electron microscopy as described in Mü ller and Wieschaus (1996). Samples were viewed under a Hitachi S800 SEM. In Vitro Protease Assays HID's ability to inhibit DIAP1 was determined from caspase activity TUNEL labeling was performed using an in situ cell death detection kit (Roche). Embryos were fixed as described above, rinsed in assay progress curves in which the release of 7-amino-4-trifluoromethyl-coumarin (AFC) from the synthetic substrate Ac-DEVD-AFC PTX (PBS, 0.5% Triton X-100), and immunolabeled with antibodies against ␤-gal (Cappel) and Cy3-conjugated goat anti-rabbit (Jack- 
